Yang, Shi-Ye
Yan, Mao-Lin
Duan, Yun-Fei
Feng, Jin-Kai
Ye, Jia-Zhou
Xiang, Yan-Jun
Liu, Zong-Han
Guo, Lei
Xue, Jie
Cheng, Shu-Qun http://orcid.org/0000-0001-6760-7470
Guo, Wei-Xing
Funding for this research was provided by:
Meng Chao Talent Training Program (EHBH2019YC112)
National Natural Science Foundation of China (82172846)
Article History
Received: 7 February 2022
Accepted: 1 May 2022
First Online: 15 June 2022
Declarations
:
: Shi-Ye Yang, Mao-Lin Yan, Yun-Fei Duan, Jin-Kai Feng, Jia-Zhou Ye, Yan-Jun Xiang, Zong-Han Liu, Lei Guo, Jie Xue, Shu-Qun Cheng and Wei-Xing Guo have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: All procedures performed in this study involving human participants were approved by the Institutional Ethics Review Board of the Eastern Hepatobiliary Surgery Hospital, Fujian Provincial Hospital, The Third Affiliated Hospital of Soochow University, and Affiliated Tumor Hospital of Guangxi Medical University. This study was in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent for study participation was obtained from all the patients.
: All authors confirm that the work described has not been published before and is not under consideration for publication elsewhere. All authors have seen and gave consent to the publication of this study. The publication of this work has been approved by the responsible authorities at the institution where the work is carried out.
: Not applicable.
: Not applicable because this is a retrospective observational study.
: For hepatocellular carcinoma (HCC) patients at BCLC stages 0–A with or without microvascular invasion (MVI), laparoscopic liver resection may be a safe and feasible alternative to laparotomic liver resection.